Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 6/2017

01-06-2017 | Letter to the Editor

Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major

Authors: Elisa Biliotti, Donatella Palazzo, Marco Serani, Alessandro M. Silvestri, Lorenzo Volpicelli, Rozenn Esvan, Cristiana Franchi, Martina Spaziante, Francesco Sorrentino, Gloria Taliani

Published in: Annals of Hematology | Issue 6/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Di Marco V, Capra M, Gagliardotto F, Borsellino Z, Cabibi D, Barbaria F et al (2008) Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Haematologica 93(8):1243–1246CrossRefPubMed
2.
Gollo G, Savioli G, Balocco M, Venturino C, Boeri E, Costantini M, Forni GL (2013) Changes in the quality of life of people with thalassemia major between 2001 and 2009. Patient Prefer Adherence 7:231–236PubMedPubMedCentral
3.
Dhirar N, Khandekar J, Bachani D, Mahto D (2016) Thalassemia major: how do we improve quality of life? Spring 5(1):1895CrossRef
4.
Di Marco V, Capra M, Angelucci E, Borgna-Pignatti C, Telfer P, Harmatz P et al (2010) Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 116(16):2875–2883CrossRefPubMed
5.
Asselah T, Boyer N, Saadoun D, Martinot-Peignoux M, Marcellin P (2016) Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives. Liver Int 36:47–57CrossRefPubMed
6.
Talavera Pons S, Boyer A, Lamblin G, Chennell P, Châtenet F-T, Nicolas C et al (2017) Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C. Br J Clin Pharmacol 83(2):269–293
7.
Fraquelli M, Cassinerio E, Roghi A, Rigamonti C, Casazza G, Colombo M et al (2010) Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol 85(8):564–568CrossRefPubMed
8.
Bachofner JA, Valli PV, Kröger A, Bergamin I, Künzler P, Baserga A et al (2017) Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index. Liver Int 37(3):369–376
9.
Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F (2005) Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 41(4):790–800CrossRefPubMed
Metadata
Title
Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major
Authors
Elisa Biliotti
Donatella Palazzo
Marco Serani
Alessandro M. Silvestri
Lorenzo Volpicelli
Rozenn Esvan
Cristiana Franchi
Martina Spaziante
Francesco Sorrentino
Gloria Taliani
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 6/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-2986-x

Other articles of this Issue 6/2017

Annals of Hematology 6/2017 Go to the issue

Letter to the Editor

Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma

Letter to the Editor

Causes of hospital admission in children and adults with transfusion-dependent thalassemia in Sardinia, 2000–2015

Original Article

Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma

Letter to the Editor

Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib

Original Article

Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?

Original Article

Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits